Copeland Capital Management 13D and 13G filings for LeMaitre Vascular, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-24 1:34 pm Purchase | 2024-12-31 | 13G | LEMAITRE VASCULAR, INC LMAT | Copeland Capital Management | 988,980 5.210% | 3,461 (+0.35%) | Filing |
| 2024-10-22 3:49 pm Sale | 2024-09-30 | 13G | LEMAITRE VASCULAR, INC LMAT | Copeland Capital Management | 985,519 5.180% | -274,442 (-21.78%) | Filing |
| 2024-01-22 09:58 am Sale | 2023-12-31 | 13G | LEMAITRE VASCULAR, INC LMAT | Copeland Capital Management | 1,259,961 5.700% | -17,517 (-1.37%) | Filing |
| 2023-01-13 12:45 pm Purchase | 2022-12-31 | 13G | LEMAITRE VASCULAR, INC LMAT | Copeland Capital Management | 1,277,478 6.200% | 72,279 (+6.00%) | Filing |
| 2022-01-26 4:43 pm Purchase | 2021-12-31 | 13G | LEMAITRE VASCULAR, INC LMAT | Copeland Capital Management | 1,205,199 5.500% | 1,205,199 (New Position) | Filing |